Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Jeffrey S. Aronin
EtÓ : 52
Patrimonio pubblico : 1 720 269 USD
Principali societÓ : Discover Financial Services - Harmony Biosciences Holdings, Inc.
Riassunto 
Founder of 7 different companies, which include: OVATION Pharmaceuticals, Inc., Paragon Biosciences LLC and Emalex Biosciences, Inc. Jeffrey S. Aronin is an entrepreneur and businessperson who has been at the head of 10 different companies and occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Co-Chairman of MATTER Chicago (which he founded), Non-Executive Chairman for Harmony Biosciences Holdings, Inc., Chairman & Chief Executive Officer of Paragon Biosciences LLC (which he founded in 2010), Chairman & Chief Executive Officer for Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Mr. Aronin is also on the board of 14 other companies.

In the past Mr. Aronin held the position of Chairman & Chief Executive Officer for Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer at Enterprise Technologies, Inc., President & Chief Executive Officer of OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer at Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Posti e reponsabilitÓ di Jeffrey S. Aronin 
NomeTitolo Da
Discover Financial Services
(Banche)
Independent Director 2008
Harmony Biosciences Holdings, Inc.
(Prodotti farmaceutici)
Non-Executive Chairman 2017
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Castle Creek Biosciences, Inc. Chairman 2018
MATTER Chicago Co-Chairman -
CIRC Biosciences, Inc. Director -
The University of Chicago Medical Center Director -
Skyline Biosciences LLC Director -
Qlarity Imaging LLC Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Castle Creek Pharmaceutical Holdings, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Paragon Biosciences Emalex Capital, Inc. Director -
Harmony Biosciences LLC Director -
Castle Creek Pharmaceuticals LLC Director 2015
Ravinia Festival Association Trustee -
Pharmaceutical Research & Manufacturers of America Director 2010
The Commercial Club of Chicago Director -
The Aspen Institute, Inc. Director -


Participazioni di Jeffrey S. Aronin 
NomeAzioni%Valorizzazione
Discover Financial Services (DFS)
(Banche)
14 0030,0047%1 720 269 USD


Jeffrey S. Aronin: network personale 
Le notizie pi¨ lette 
12/10CATHIE WOOD: Wood di ARK Invest avverte che la prossima flessione economica in Cina è "ovvia".
MR
15/10JACK DORSEY: Il CEO di Square Dorsey dice che sta cercando di costruire un sistema di estrazione di bitcoin - tweet
MR
12/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore", dovuto alla regolamentazione
MR
13/10WARREN BUFFETT: Nubank, sostenuta da Buffett, realizza un profitto in Brasile
MR
22/10WARREN BUFFETT: Buffett offre il suo 6,9% di Cattolica nell'offerta di Generali
MR
21/10ELON MUSK: Nessun Elon Musk Show durante questa chiamata trimestrale di Tesla
MR
20/10ANDREA ORCEL: Ubs aveva avvertito Santander che avrebbe applicato norme su compensi a Orcel
RE
11/10JAMIE DIMON: JPMorgan's Dimon fa esplodere il bitcoin come "senza valore
MR
01:46TED ROGERS: È improbabile che il dramma del consiglio di amministrazione di Rogers influenzi l'accordo per l'acquisto di Shaw - analisti
MR
22/10TED ROGERS: I risultati del terzo trimestre di Rogers potrebbero essere eclissati da una disputa nel consiglio di amministrazione
MR
Pi¨ notizie


© 2021 People and Ownership :   
Jeffrey S. Aronin : connessioni